Targeted therapy of schwannoma cells in immunocompetent rats with an erbB2-specific antibody-toxin

International Journal of Cancer

Volumn 73, Issue 1, 1997, Pages 117-124

  Altenschmidt, Uwe ^a   Schmidt, Mathias ^a   Groner, Bernd ^a   Wels, Winfried ^a  

^a TUMOR BIOLOGY CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOTOXIN; PROTEIN TYROSINE KINASE; RECOMBINANT SINGLE CHAIN ANTIBODY TOXIN SCFV; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY SPECIFICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; NEURILEMOMA; NONHUMAN; PRIORITY JOURNAL; RAT; TARGET CELL;

ADP RIBOSE TRANSFERASES; ANIMALS; ANTIBODIES, NEOPLASM; ANTIBODY SPECIFICITY; BACTERIAL TOXINS; EXOTOXINS; FEMALE; HUMANS; IMMUNOTOXINS; MICE; NEURILEMMOMA; RATS; RECEPTOR, ERBB-2; RECOMBINANT FUSION PROTEINS; SKIN NEOPLASMS; VIRULENCE FACTORS;

EID: 0030873969     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970926)73:1<117::AID-IJC18>3.0.CO;2-D     Document Type: Article

References (28)

1. ALLURED, V.S., COLLIER, R.J., CARROLL, S.F. and MCKAY, D.B., Structure of exotoxin A of Pseudomonas aeruginosa at 3.0 angström rosolution. Proc. nat. Acad. Sci. (Wash.), 83, 1320-1324 (1986).
2. ALTENSCHMIDT, U., KAHL, R., KLUNDT, E., STÖCKLIN, E., MIHATSCH, M., WEINDEL, K. and GRONER, B., Schwannoma cells induce a tumor-cell-specific cytotoxic-T-cell response upon transplantation into syngeneic rats, but escape elimination through the secretion of immunosuppressive factors. Int. J. Cancer. 70, 542-550 (1997).
3. ALTENSCHMIDT, U., KAHL, R., MORITz, p., SCHNIERLE, B., GERSTMATYER, B., WELS, W. and GRONER, B., Cytolysis of tumor cells expressing the Neu/erbB-2, erbB-3 and erbB-4 receptors by genetically targeted, naive T lymphocytes. Clin. Cancer Res., 2, 1001-1008 (1996).
4. ARTEAGA, C.L., HIRD, S.D., WINNIER, A.R., JOHNSON, M.D., FENDLEY, B.M. and FORBLES, J.T., Anti-transforming growth factor (TGF-β) antibodies inhibit breast-cancer cell tumorigenicity and increase mouse spleen natural-killer-cell activity. J. clin. Invest., 92, 2569-2576 (1993).
5. BASELGA, J. and MUNDELSOHN, J., The epidermal-growth-factor receptor as a target for therapy in breast carcinoma. Breast Cancer Res. Treat., 29, 127-138 (1994).
6. HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J. clin. Oncol., 14, 737-744 (1996).
7. BOLIVAR, F. and BACKMAN, K., Plasmids of Escherichia coli us cloning vectors. Meth. Enzymol., 68, 245-267 (1979).
8. GRONER, B., WICK, B., JHSCHKE, M., FIEBIG, H., DENGLER, W., RUNAU, T., MIHATSCH, M., KAHL, R., SCHMIDT, M., WELS, W. and STÖCKLIN, E., Intratumoral application of a heregulin-exotoxin-A fusion protein causes rapid tumor regression without adverse systemic or local effects. Int. J. Cancer, 70, 682-687 (1997).
9. GULLICK, W.J., Prevalence of aberrant expression of the epidermal-growth-factor receptor in human cancers. Brit. med. Bull., 47, 87-98 (1991).
10. HALL, W.A., MYKLEBUST, A., GODAL, A., NESLAND, J.M. and FODSTAD, O., In vivo efficacy of intrathecal transferrin-Pseudomonas-exotoxin-A immunotoxin against LOX melanoma, Neurosurgery, 34, 649-655 (1994).
11. HARWERTH, I.-M., WELS, W., MARTE, B.M. and HYNES, N.E., Monoclonal antibodies against the extracellular domain of the erbB-2-receptor function as partial ligand agonists. J. biol. Chem., 267, 15160-15167 (1992).
12. HWANG, J., FITZGERALD, D.J., ADHYA, S. and PASTAN, L., Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli. Cell, 48, 129-136 (1987).
13. HYNES, N.E. and STERN, D.F., The biology of erbB-2/neu/HER-2 and its role in cancer. Biochem, biophys. Acta, 1198, 165-184 (1994).
14. JANNOT, C.B., BEERLI, R.R., MASON, S., GULLICK, W.J. and HYNES, N.E., Intracellular expression of a single-chain antibody directed to the EGFR leads to growth inhibition of tumor cells. Oncogene. 13, 275-282 (1996).
15. JESCHKE, M., WELS, W., DENGLER, W., IMBHR, R., STÖCKLIN, E. and GRONER, B., Targeted inhibition of tumor-cell growth by recombinant heregulintoxin fusion proteins. Int. J. cancer, 60, 730-739 (1995).
16. NIKITN, A.Y. JIN, J.J., PAPEWALIS, J., PRKOPENKO, S.M., POZHARISSKI, A. and RAJEWSKY, M.F., Wild-type neu transgene counteracts mutant homologue in malignant transformation of rat Schwann cells. Oncogene, 12. 1309-1317 (1996).
17. OGATA, M., FRYLING., C.M., PASTAN, I. and FITZGFRALD, D.J., Cell-mediated cleavage of Pseudomonas exotoxin between Arg279 and Gly280 generates the enzymatically active fragment which translocates to the ecytosol J. biol. Chem., 267, 25396-25401 (1492).
18. PASTAN. I. and FITZGERALD, D., Recombinant toxins for cancer treatment. Science, 254, 1173-1177 (1941).
19. PELES, E. and YARDEN, Y. Neu and its ligands: from an oncogene to neural factors. Bioessays, 15, 815-824 (1993).
20. RREIMANN K.A., TURNER, S., LAMBERT, J.M., REED, M.H., SCHLOSSMAN, S.F. and LETVIN, N.L., In vivo administration of lymphocyte-specific monoclonal antibodies in non-human primates. Evidence that humoral immune response to monoclonal antibodies and immunotoxin conjugates abrogates their cytotoxic activity. Transplantation, 48, 906-912 (1989).
21. SCHLEGEL, J., ULLRICH, B., STUMM, G., GASS, P., HARWERTH, I.-M., HYNES, N.E. and KIESSLING, M., Expression of the c-erbB-2 encoded oncoprotein and progesterone receptor in human meningiomas. Acta neuropathol., 86, 473-479 (1993).
22. SCHMIDT, M., HYNES, N.B., GRONER, B. and WELS, W., A bivalent single-chain antibody-toxin specific for ErbB-2 and the EGF receptor. Int. J. Cancer, 65, 538-546 (1996).
23. SCHMIDT, M., VAKALOPOULOU, E., SCHNEIDER, D.W. and WELS, W., Construction and functional characterization of scFv(14E1)-ETA - a novel, highly potent antibody toxin specific for the EGF receptor. Brit. J. Cancer, 75, 1575-1584 (1997).
24. SCHMIDT, M. and WELS, W., Targeted inhibition of tumor-cell growth by a bispeciric single-chain toxin containing an antibody domain and TGFα. Brit. J. Cancer, 74, 853-862 (1996).
25. SCHWECHHEIMER, K., LAUFLH, R.M., SCHMAHL, W., KNODLSEDER, M., FISCHER, H. and HOFLER, H., Expression of neu/c-erbB-2 in human brain tumors. Hum. Pathol., 25, 772-780 (1994).
26. erbB-2-specific single-chain antibody toxins differ in their cell-killing activity on tumor cells expressing both receptor proteins. Int. J. Cancer. 60, 137-144 (1995).
27. WELS, W., HARWERTH, I.M., MÜLLER, M., GRONER, B. and HYNES, N.E., Selective inhibition of tumor-cell growth by a recombinant single-chain antibody toxin specific for the erbB-2 receptor. Cancer Res., 52, 6310-6317 (1992).
28. WINTER, G. and MILSTEIN, C., Man-made antibodies. Nature (Lond.) 349, 293-299 (1991).